COMPANY · NIPC 503320668
MATERFARMA - PRODUTOS FARMACEU
This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.
Portal BASE records €78,898.10 across 18 contracts.
Identification
| Company name | MATERFARMA - PRODUTOS FARMACEU |
|---|---|
| NIPC | 503320668 |
None of the registers we read (GLEIF, TED and contract documents) identifies this company; the name comes from Portal BASE contracts.
Contracted money
Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.
| Year | Contracts | Contract value |
|---|---|---|
| 2016 | 1 | €1,079 |
| 2017 | 1 | €83 |
| 2019 | 3 | €26,982 |
| 2020 | 3 | €26,691.50 |
| 2021 | 3 | €2,330.85 |
| 2022 | 2 | €10,382.75 |
| 2023 | 1 | €850 |
| 2025 | 2 | €5,499 |
| 2026 | 2 | €5,000 |
| Name | Contracts | Contract value |
|---|---|---|
| Centro Hospitalar Vila Nova de Gaia (CHNVG) | 1 | €25,488 |
| Centro Hospitalar Vila Nova de Gaia - Espinho, E. P. E. | 1 | €25,488 |
| Centro Hospitalar Universitário de Lisboa Norte, E. P. E. | 2 | €9,936.75 |
| Unidade Local de Saúde de Lisboa Ocidental, EPE | 2 | €8,649 |
| Direção-Geral de Reinserção e Serviços Prisionais | 2 | €1,852.85 |
| Unidade Local de Saúde do Algarve, EPE | 2 | €1,850 |
| Hospital Garcia de Orta, E. P. E. | 1 | €1,328 |
| Unidade Local de Saúde do Norte Alentejano, E. P. E. | 2 | €1,090 |
| Centro Hospitalar de Lisboa Central, E. P. E. | 1 | €1,079 |
| Unidade Local de Saúde do Algarve, E. P. E. | 1 | €850 |
| Name | Contracts | Contract value |
|---|---|---|
| Vila Nova de Gaia | 2 | €50,976 |
| Lisboa | 6 | €20,245.75 |
| Oeiras | 2 | €1,852.85 |
| Almada | 1 | €1,328 |
| Elvas | 2 | €1,090 |
| Portalegre | 2 | €1,090 |
| Faro | 2 | €705.50 |
| Subject | Year | Contract value |
|---|---|---|
| BACILO CALMETTE- GUÉRIN 2*10e8 - 3*10e9 UFC RIVM BCGpó susp ivesical FR IVesic ano 2020 (procedimento no 1192620) | 2020 | €25,488 |
| Bacilo Calmette- Guérin 2*10e9 UFR RIVM BCG Pó SUSP ivesical FR IVesic ano 2020 (2) (AD 1731419) | 2019 | €25,488 |
| 221G000193 - Aq cinchocaina 15 pomada bisnaga 20 g | 2022 | €9,065.25 |
| 111021725- Aquisição Medicamentos Exclusivos Materfarma | 2025 | €4,599 |
| 111002726-AQUISIÇÃO MEDICAMENTO CINCHOCAINA EXCLUSIVOS MATERFARMA - 2026 | 2026 | €4,050 |
Who they competed with
The IMPIC files list no competitors for this company's contracts.
The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.
Links read in contract documents
Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.
The documents we read show no links between these companies.
Investigations that mention it
No published investigation mentions this company by NIPC.